1. Calcitriol Reduces the Inflammation, Endothelial Damage and Oxidative Stress in AKI Caused by Cisplatin
    Beatriz M. Oliveira et al, 2022, International Journal of Molecular Sciences CrossRef
  2. Chemoradiotherapy and nanomedicine: Drug mechanisms and delivery systems
    Matthew Molinaro et al, 2024, WIREs Nanomedicine and Nanobiotechnology CrossRef
  3. Structural basis of methotrexate and pemetrexed action on serine hydroxymethyltransferases revealed using plant models
    Milosz Ruszkowski et al, 2019, Scientific Reports CrossRef
  4. Assessment of Early Growth Response 1 in Tumor Suppression of Esophageal Squamous Cell Carcinoma
    Yen-Chiang Tseng et al, 2022, Journal of Clinical Medicine CrossRef
  5. Cisplatin/fluorouracil/pemetrexed
    , 2017, Reactions Weekly CrossRef
  6. Downregulation of KLF10 contributes to the regeneration of survived renal tubular cells in cisplatin-induced acute kidney injury via ZBTB7A-KLF10-PTEN axis
    Yang Zhang et al, 2023, Cell Death Discovery CrossRef
  7. Uncovering cancer vulnerabilities by machine learning prediction of synthetic lethality
    Salvatore Benfatto et al, 2021, Molecular Cancer CrossRef
  8. Mechanisms of Cisplatin-Induced Acute Kidney Injury: Pathological Mechanisms, Pharmacological Interventions, and Genetic Mitigations
    Kristen Renee McSweeney et al, 2021, Cancers CrossRef
  9. Comparative analyses of paclitaxel/carboplatin with cisplatin/5-fluorouracil-based chemoradiation in locally advanced inoperable upper and middle third esophageal cancer
    Divyesh Kumar et al, 2022, Journal of Cancer Research and Therapeutics CrossRef
  10. Squamous Cell Carcinoma of the Esophagus
    D. Chamil Codipilly et al, 2022, Gastroenterology Clinics of North America CrossRef
  11. Definitive concurrent chemoradiotherapy with paclitaxel plus carboplatin is superior to cisplatin plus 5‐fluorouracil in patients with inoperable esophageal squamous cell carcinoma using retrospective, real‐world evidence
    Jason Chia‐Hsun Hsieh et al, 2021, Cancer Medicine CrossRef
  12. Protective effects of ginsenosides in cisplatin-induced kidney injury
    Xinyi Luo et al, 2023, Indian Journal of Pharmacology CrossRef
  13. Assessing the prevalence and severity of cisplatin-induced nephrotoxicity in a minority- low socioeconomic population in the Bronx, New York
    M Bakri Hammami et al, 2024, Journal of Chemotherapy CrossRef
  14. The Protective Effect of Marsdenia tenacissima against Cisplatin-Induced Nephrotoxicity Mediated by Inhibiting Oxidative Stress, Inflammation, and Apoptosis
    Zhiguang Zhang et al, 2023, Molecules CrossRef
  15. Hypoxia induces chemoresistance of esophageal cancer cells to cisplatin through regulating the lncRNA-EMS/miR-758-3p/WTAP axis
    Zi-Jiang Zhu et al, 2021, Aging CrossRef